Sagility India Limited (NSE: SAGILITY, BSE: 544282), a leading provider of technology-enabled business solutions for the U.S. healthcare industry, has announced strong financial results for the first quarter of fiscal year 2026, ending June 30, 2025.

Financial Highlights

• Revenue reached ₹15,389.00 million ($180.40 million), marking a 25.8% year-over-year growth (23.1% in constant currency terms).
• Organic year-over-year growth stood at 17.9% (15.4% in constant currency terms).
• Adjusted EBITDA was ₹3,687.00 million ($43.20 million), representing 24.0% of revenue and a 26.5% year-over-year increase.
• Adjusted PAT (Profit After Tax) came in at ₹1,997.00 million ($23.40 million), or 13.0% of revenue, showing a 38.0% year-over-year growth.
• Basic Earnings Per Share (EPS) reached ₹0.32, a substantial 530.0% year-over-year increase.
• Adjusted Basic EPS was ₹0.43, up 30.5% year-over-year.

Operational Highlights

• The company's workforce expanded to 39,917 employees by the end of Q1.
• Sagility now operates across 5 countries with 33 delivery centers.
• The company added 4 new clients during the quarter, bringing the total active client groups to 77.
• Sagility won $32.00 million in new business and expansions (potential steady state Annual Contract Value) in Q1 FY26.

Strategic Developments

Ramesh Gopalan, Managing Director and Group CEO, commented on the results: "We've entered FY26 with strong momentum and confidence in our position as a leading provider of solutions and services for U.S. healthcare payers and providers. Despite ongoing regulatory and policy shifts, our business continues to demonstrate resilience and sustained growth. We are deepening engagement with both long-standing and newer clients, while maintaining robust profitability. The integration of BroadPath is progressing smoothly."

Sarvabhouman Srinivasan, Group Chief Financial Officer, added: "We have started FY26 with a healthy revenue momentum and disciplined execution driving balanced financial performance. Margins remain stable, supported by improved delivery efficiency, cost optimization, and early gains from BroadPath integration. Cash generation continues to be robust, enabling us to fund strategic priorities and maintain financial flexibility."

Industry Recognition

Sagility has received notable industry recognition:

• Named a Leader by Avasant in the Healthcare Payer Business Process Transformation 2025 RadarView.
• Named a Leader by Avasant in the Clinical and Care Management Business Process Transformation 2025 RadarView.
• Won the "Most Preferred Workplace FY26" award by Marksmen Daily.

Client Diversification

The company has shown progress in diversifying its client base:

Looking Ahead

With a strong start to FY26, Sagility India Limited appears well-positioned to capitalize on the growing demand for healthcare business process management services. The company's focus on deepening client relationships, operational efficiency, and strategic integrations is likely to drive continued growth and profitability in the coming quarters.

As the healthcare industry continues to evolve, Sagility's investments in automation and AI capabilities are expected to play a crucial role in delivering improved efficiencies and better business outcomes for its clients.

Sagility B.V. has made a strategic move in the ongoing Offer for Sale (OFS) of Sagility India , demonstrating increased confidence in the company's potential. The Dutch firm has exercised an oversubscription option, allowing it to sell an additional 7.62% stake in the Indian entity.

Oversubscription Highlights Strong Investor Interest

The decision to exercise the oversubscription option comes as a clear indicator of robust investor demand for Sagility India's shares. This move enables Sagility B.V. to offload a larger portion of its holdings than initially planned, capitalizing on the strong market interest.

Implications for Sagility India

For Sagility India, this development could potentially lead to:

• Increased Market Liquidity: A larger float of shares in the market could enhance trading volumes and liquidity for the stock.
• Broader Investor Base: The additional shares made available through the oversubscription may attract a wider range of investors, potentially including both institutional and retail participants.
• Market Validation: The strong demand implied by the oversubscription could be seen as a vote of confidence in Sagility India's business model and growth prospects.

What This Means for Investors

Investors and market watchers should note that the exercise of an oversubscription option often signals:

• Strong market appetite for the company's shares
• Potential for increased trading activity in the short term
• Possible adjustments in the stock's ownership structure

While the exact pricing details of the OFS and the oversubscription have not been disclosed, the move suggests a positive reception from the market.

Looking Ahead

As the Offer for Sale progresses, market participants will be keen to observe the final allocation of shares and any subsequent impact on Sagility India's stock price and trading patterns. The successful execution of the oversubscription option may also set a positive tone for future capital market activities by the company.

Investors are advised to monitor official communications from Sagility India and regulatory filings for further details on the OFS and its outcomes.